UroGen Pharma Ltd. (URGN) Net margin 2016–2025
UroGen Pharma Ltd. (URGN) net profit margin by fiscal year — reported net income divided by reported revenue.
-139.8%FY2025 · since FY2016: -11.1% → -139.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -139.8% | +0.5 pp |
| FY2024 | -140.4% | -16.7 pp |
| FY2023 | -123.6% | +47.0 pp |
| FY2022 | -170.6% | +60.1 pp |
| FY2021 | -230.7% | +858.3 pp |
| FY2020 | -1088.9% | +583055.5 pp |
| FY2019 | -584144.4% | -577437.3 pp |
| FY2018 | -6707.2% | -6462.0 pp |
| FY2017 | -245.2% | -234.1 pp |
| FY2016 | -11.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice